Share on StockTwits

Now it’s not just two Americans, but a Spaniard, as well: the three non-Africans known to have Ebola got some of the very few doses that exist of an experimental drug aimed at treating the deadly disease. None of the more than 1,700 Africans sickened by Ebola have received this treatment. The drug, “ZMapp,” is so novel and unproven that not much is available and its effectiveness remains unknown. But many Africans are seeing a larger, bitter truth in the fact that two Americans and a Spaniard were able to get this treatment after being infected in West Africa, where the hemorrhagic fever has raged for months.



“Ethics Test: Who Gets Experimental Ebola Drug?” is categorized as “world”. This video was licensed from Grab Networks. For additional video content, click the “video” tab at the top of this page.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.